fbpx

Reminder: April 15 for Turning in New Agent Agreement to ABN

April 15 (tax day) is also the deadline for any existing Agent signed to our old agreement to have their new Agent Agreement signed and on file with A. B. Nicholas. 

Any pre-existing Agent who has not signed by that date, will be removed from the Agent portal and resources and will need to reapply in the future as a new Agent applicant if they should seek to refer clients into the LeverageLine program. 

In addition, all Agents who seek to receive fees on their referrals will need to pass the Compliance Exam with a score of 100%. You may take the exam repeatedly until this score is received so that we may place it on file for regulatory compliance purposes. 

If you do not have the new Agent Agreement, please contact Marie Wood (marie@abnicholas.com, 202.379.4744 ext 2). 

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Related Posts

Have Us Speak to Your Salesforce about LeverageLine Credit Lines for Stock Portfolio Owners.

We offer what is arguably the best stock loan program in the U. S. market today, with the lowest rates and highest loan-to-value plus quickest delivery of funds in the nation for a 100% secure, licensed, FINRA-member-managed program. We are A. B. Nicholas, and securities finance is what we do and have done exclusively for over a decade. We have three major household-name licensed institutional brokerages who have agreed to

Why an A. B. Nicholas Stock Loan and Not One from Your Current Brokerage?

When it comes to money, there is a reason why so many financial institutions have named themselves with words like “Trust”, “Fidelity” or “Assurance” for example. That’s because outside perhaps of the medical profession, nowhere else in human life is trust and confidence in the efficacy, honesty, and integrity of a company (or individual) more important.  This applies to stocks, bonds, mutual funds, and so forth too. It is also

A Stock Loan Against Your Cannabis Stock Portfolio? Yep, We Can…

If you have been an investor in one of the many cannabis-related stocks that have sprung up on the boards over the past several years, you’ve probably been stymied when it came to taking out a margin loan against them. Because of the still-existing federal treatment of marijuana as a drug, major banks and brokerages have been unwilling or unable to provide the normal lending facilities against these stocks that

Join Our Weekly Newsletter

We do not sell, communicate or divulge your information to any third-parties.